Mid-Year Report — VIZIENT, INC. for VIZIENT INC (2007)

Firm

VIZIENT, INC.

Client

VIZIENT INC

Income

—

Expenses

$120,000

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Not-for-profit hospital tax exemption-general outreach and education efforts in House and Senate related to hospital Community Benefit Standard Supported increasing tax on tobacco products to fund reauthorization of State Children's Health Insurance Program

Lobbyist	Covered position, as disclosed
EDWARD GOODMAN	N/A
CIDETTE PERRIN	N/A
STEVEN RIXEN	LEGISLATIVE CORRESPONDENT-U.S.S. BYRON DORGAN

Contacted: Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Supported Mandating Unique Device Identification for medical devices in House and Senate Medical Device User Fee legislation (H.R. 2900, S. 1082) Hospital Group Purchasing-General outreach and education efforts 340 B (of the Public Health Services Act) Drug Pricing Program legislative proposals (H.R. 2606, S. 1376) Healthcare Information Technology-General outreach and education efforts related to privacy aspects and Stark and Anti-kickback provisions in possible legislation. State Children's Health Insurance Program reauthorization and inclusion of specific provisions related to legal immigrant children and funding sources Funding for Nursing Workforce Development Programs (Labor-HHS-Education Appropriations)

Lobbyist	Covered position, as disclosed
EDWARD GOODMAN	N/A
CIDETTE PERRIN	N/A
STEVEN RIXEN	LEGISLATIVE CORRESPONDENT-U.S.S. BYRON DORGAN

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE

Bills named: S. 1376 (110th), H.R. 2606 (110th), H.R. 2900 (110th), S. 1082 (110th)

Medicare/Medicaid MMM

Medicaid and Medicare regulatory cuts in President's proposed FY 2008 Budget and proposed regulation CMS-2258-P FY 2008 Inpatient Prospective Payment System Gainsharing-Centers for Medicare and Medicaid Services demonstration projects

Lobbyist	Covered position, as disclosed
EDWARD GOODMAN	N/A
CIDETTE PERRIN	N/A
STEVEN RIXEN	LEGISLATIVE CORRESPONDENT-U.S.S. BYRON DORGAN

Contacted: Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.